期刊文献+
共找到268篇文章
< 1 2 14 >
每页显示 20 50 100
Role of Tissue Factor Pathway Inhibitor-2 in Ovarian Tumor Migration and Invasion 被引量:2
1
作者 仲任 黄瑞滨 宋善俊 《The Chinese-German Journal of Clinical Oncology》 CAS 2005年第1期53-55,68-69,共5页
Objective: To elucidate the relation between human tissue factor pathwayinhibitor-2 (TFPI-2) expression and ovarian tumor migration and invasion. Methods: Human TFPI-2expression vector pBos-Cite-neo/TFPI-2 was transfe... Objective: To elucidate the relation between human tissue factor pathwayinhibitor-2 (TFPI-2) expression and ovarian tumor migration and invasion. Methods: Human TFPI-2expression vector pBos-Cite-neo/TFPI-2 was transfected into ovarian tumor cells line A2780- Afterthe transfected cells were selected by G418, transfected and nontransfected cells were screened forTFPI-2 mRNA and protein by reverse transcription-polymerase chain reaction and Western blotanalysis, respectively. The number of transfected or nontransfected cells passing through membraneof Boyden chamber was counted as the basis assessing tumor cells migratory and invasive behaviors.Results: Expression of mRNA and protein of TFPI-2 was detectable in transfected cells. In invasionassay, the number of TFPI-2-expressing cells to traverse a Matrigel-coated membrane was obviouslydecreased compared with that of nonexpressing cells (59.3±6.5 vs 109.7±5.5, P 【 0.01); While inmigration assay, no significant difference through a noncoated membrane was observed amongtransfected and nontransfected cells (114.7±8.6 vs 127.3±7.1, P 】 0.05). Conclusion: Expression ofTFPI-2 may strongly inhibit the invasive ability of ovarian tumor cells in vitro, but has no effecton the migratory ability which provides an experimental basis for genotherapy of human ovariantumor. 展开更多
关键词 tissue factor pathway inhibitor-2 ovarian tumor INVASION MIGRATION
下载PDF
Expressions of Tissue Factor and Tissue Factor Pathway Inhibitor in Patients with Acute Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
2
作者 郝琎琎 黎玮明 +3 位作者 邹萍 李泉 夏凌辉 游泳 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2009年第6期697-700,共4页
This study examined the expressions of human serum tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell ... This study examined the expressions of human serum tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and their clinical significance. The serum TF and TFPI levels were detected by ELISA in 28 allo-HSCT recipients before and after the transplanta-tion and the changes of TF and TFPI levels were dynamically monitored at different phases of the disease. No significant differences in the serum TF and TFPI levels were found in allo-HSCT recipi-ents in the absence of aGVHD or with gradeⅠaGVHD before and after the transplantation. The lev-els of serum TF and TFPI were substantially increased in the patients with gradeⅡ aGVHD at the peak of aGVHD (P〈0.05) and they were even higher in the patients with grade Ⅲ–Ⅳ aGVHD (P〈0.01). When the conditions became stable after treatment with immunosuppressive agents, the serum TFPI level was decreased to the baseline level (P〉0.05) and the TF level was lowered but still higher than the baseline level (P〈0.05). It was concluded that the levels of serum TF and TFPI were increased significantly in the patients with grade Ⅱ–Ⅳ aGVHD after allo-HSCT and decreased markedly after the treatment. Monitoring the levels of serum TF and TFPI in the patients with allo-HSCT is important to predict the occurrence, outcome and prognosis of aGVHD. 展开更多
关键词 hematopoietic stem cell transplantation graft-versus-host disease tissue factor tissue factor pathway inhibitor
下载PDF
Clinical significance of expression of tissue factor and tissue factor pathway inhibitor in ulcerative colitis 被引量:4
3
作者 Hao-Lan He Ji-Bin Zhang Qian Li 《World Journal of Gastroenterology》 SCIE CAS 2014年第23期7461-7465,共5页
AIM: To investigate the clinical significance of expression of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in ulcerative colitis (UC).
关键词 Ulcerative colitis tissue factor tissue factor pathway inhibitor
下载PDF
Testosterone alleviates tumor necrosis factor-alpha-mediated tissue factor pathway inhibitor downregulation via suppression of nuclear factor-kappa B in endothelial cells 被引量:2
4
作者 Hong Jin Wen-Bing Qiu +4 位作者 Yi-Fang Mei Qin Zhang Dong-Ming Wang Yu-Guang Li Xue-Rui Tan 《Asian Journal of Andrology》 SCIE CAS CSCD 2009年第2期266-271,共6页
We have observed earlier that testosterone at physiological concentrations can stimulate tissue factor pathway inhibitor(TFPI)gene expression through the androgen receptor in endothelial cells.This study further inves... We have observed earlier that testosterone at physiological concentrations can stimulate tissue factor pathway inhibitor(TFPI)gene expression through the androgen receptor in endothelial cells.This study further investigated the impact of testosterone on TFPI levels in response to inflammatory cytokine tumor necrosis factor-alpha(TNF-α).Cultured human umbilical vein endothelial cells were incubated in the presence or absence of testosterone or TNF-α.TFPI protein and mRNA levels were assessed by enzyme-linked immunosorbent assay and quantitative real-time reverse transcription polymerase chain reaction.To study the cellular mechanism of testosterone’s action,nuclear factor-kappa B(NF-κB)translocation was confirmed by electrophoretic mobility shift assays.We found that after NF-κB was activated by TNF-α,TFPI protein levels declined significantly by 37.3%compared with controls(P<0.001),and the mRNA levels of TFPI also decreased greatly(P<0.001).A concentration of 30 nmol L-1 testosterone increased the secretion of TFPI compared with the TNF-α-treated group.NF-κB DNA-binding activity was significantly suppressed by testosterone(P<0.05).This suggests that physiological testosterone concentrations may exert their antithrombotic effects on TFPI expression during inflammation by downregulating NF-κB activity. 展开更多
关键词 nuclear factor-kappa B TESTOSTERONE tissue factor pathway inhibitor
下载PDF
Genome-Wide Identification of Zn_(2)Cys_(6 ) Class Fungal-Specific Transcription Factors(ZnFTFs)and Functional Analysis of UvZnFTFI in Ustilaginoidea virens 被引量:5
5
作者 SONG Tianqiao ZHANG Xiong +11 位作者 ZHANG You LIANG Dong YAN Jiaoling YU Junjie YU Mina CAO Huijuan YONG Mingli PAN Xiayan QI Zhongqiang DU Yan ZHANG Rongsheng LIU Yongfeng 《Rice science》 SCIE CSCD 2021年第6期567-578,I0038,I0039,共14页
Transcription factors(TFs)orchestrate the regulation of cellular gene expression and thereby determine cell functionality.In this study,we analyzed the distribution of TFs containing domains,which named as ZnFTFs,both... Transcription factors(TFs)orchestrate the regulation of cellular gene expression and thereby determine cell functionality.In this study,we analyzed the distribution of TFs containing domains,which named as ZnFTFs,both in ascomycete and basidiomycete fungi.We found that ZnFTFs were widely distributed in these fungal species,but there was more expansion of the ZnFTF class in Ascomycota than Basidiomycota.We identified 40 ZnFTFs in Ustilaginoidea virens,and demonstrated the involvement of UvZnFTF1 in vegetative growth,conidiation,pigment biosynthesis and pathogenicity.RNA-Seq analysis suggested that UvZnFTF1 may regulate different nutrient metabolism pathways,the production of secondary metabolites,and the expression of pathogen-host interaction genes and secreted protein-encodi ng genes.Analysis of the distributi on of differe nt fungal TFs in U.virens further dem on strated that UvZnFTFs make up a large TF family and may play essential biological roles in U.virens. 展开更多
关键词 Zn_(2)Cys_(6)-type fungal-specific transcription factor Ustilaginoidea virens rice pathogen gene silencing RNA-Seq metabolism pathway effector expression pathogen-host interaction
下载PDF
Relationship between Eukaryotic Translation Initiation Factor 4E and Malignant Angiogenesis in Non-Hodgkin Lymphoma 被引量:1
6
作者 赵艳霞 刘文励 +2 位作者 周晟 周剑锋 孙汉英 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2005年第6期636-638,654,共4页
The relationship between angiogenesis and eukaryotic translation initiation factor 4E (EIF4E) expression level in non Hodgkin lymphoma (NHL) was studied. Mean microvessel density (MVD) and EIF4E were detected in... The relationship between angiogenesis and eukaryotic translation initiation factor 4E (EIF4E) expression level in non Hodgkin lymphoma (NHL) was studied. Mean microvessel density (MVD) and EIF4E were detected in 52 lymph node samples paraffin sections of patients with newly diagnosed NHL by the way of immunohistochemistry. Antisense EIF4E cDNA was cloned into plasmid pcDNA3.1 (+) and transfected into Raji cells. A series of angiogenesis related factors,including vascular endothelial growth factor (VEGF), matrix metalloproteinases 9 (MMP-9) and tissue inhibitor of metalloproteinases-2 (TIMP-2) proteins were detected by Western blot. The results showed that: (1) The Expression of EIF4E and MVD was higher in aggressive lymphomas than in indolent lymphomas(P〈0.05)and the expression of EIF4E was positively correlated with MVD in lymph node of NHL(r=0. 695, P〈0.01). (2) Antisense EIF4E eukaryocytic expression vector (pcDNA3. 1-EIF4Eas) was constructed successfully. (3) EIF4E, VEGF and MMP-9 were expressed at high levels in Raji cells as compared to normal human peripheral blood monocular cells (NHPMC), and blockage of EIF4E expression brought down the expression of VEGF and MMP-9. However, TIMP-2 was undetectable in Rail cells, although a moderate level of TIMP-2 was detected in NHPMC. It was concluded that the increased EIF4E expression was associated with aggressive property of NHL. 展开更多
关键词 eukaryotic translation initiation factor 4E non-Hodgkin lymphoma matrix metalloproteinases 9 tissue inhibitor of metalloproteinases-2
下载PDF
Nrf2-inducing and HMG-CoA reductase inhibitory activities of a polyphenol-rich fraction of Guazuma ulmifolia leaves
7
作者 Sulistiyani Syamsul Falah +5 位作者 Wulan Tri Wahyuni Dimas Andrianto Arthur Ario Lelono Waras Nurcholis Valeri Mossine Mark Hannink 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2019年第9期389-396,共8页
Objective: To fractionate and identify polyphenols from Guazuma ulmifolia Lam. leaves, and to explore their antioxidant, 5-hydroxy-3-methylglutaryl-coenzyme A(HMG-Co A) reductase inhibitory, and Nrf2 modulatory activi... Objective: To fractionate and identify polyphenols from Guazuma ulmifolia Lam. leaves, and to explore their antioxidant, 5-hydroxy-3-methylglutaryl-coenzyme A(HMG-Co A) reductase inhibitory, and Nrf2 modulatory activities.Methods: The 1,1-diphenyl-2-picrylhydrazyl assay was used to evaluate the antioxidant activity of a polyphenolic fraction of the extract of Guazuma ulmifolia Lam. leaves. THP-1 gene reporter cell lines constructed with a transcriptional response element specific for Nrf2 and a minimal promoter for the firefly luciferase–green fluorescent protein transgene were used to determine the effect of the polyphenolic fraction on the Nrf2 signaling pathway. Furthermore, an assay of HMG-Co A reductase inhibitory activity was performed by using a commercial enzyme kit. Polyphenolic compounds were identified by liquid chromatographytandem mass spectrometry.Results: The polyphenolic fraction showed fairly strong antioxidant activity [IC50 =(14.90 ± 4.70) μg/m L] and inhibited HMG-Co A reductase activity by 69.10%, which was slightly lower than that by pravastatin(84.37%) and quercetin(84.25%). Additionally, the polyphenolic fraction activated the Nrf2 antioxidant signaling pathway at 500 μg/m L. Eleven subfractions resulting from the column chromatography separation of the polyphenolic fraction also showed relatively strong antioxidant activities(IC50: 17.46–217.14 μg/m L). The subfraction(F6) stimulated the Nrf2 signaling pathway and had HMG-Co A reductase inhibitory activity(65.43%). Moreover, the subfraction contained two main flavonoids: quercetin and quercimeritrin.Conclusions: The polyphenolic fraction of Guazuma ulmifolia could induce antioxidant genes via the Nrf2/antioxidant regulatory elements pathway, and is a promising candidate for an inhibitor of HMG-Co A reductase. 展开更多
关键词 ANTIOXIDANT signaling HMG-Co A REDUCTASE inhibitor POLYPHENOLS Antioxidant-related transcription factor NRF2 REPORTER gene cell-based assay
下载PDF
尿TIMP-2与IGFBP7的乘积对重症急性胰腺炎相关性急性肾损伤的早期预测价值
8
作者 杜学芳 马尚超 +3 位作者 张利利 姬娟娟 张超群 崔艳 《河南医学研究》 CAS 2024年第18期3330-3334,共5页
目的探究尿基质金属蛋白酶抑制因子-2(TIMP-2)与胰岛素样生长因子结合蛋白7(IGFBP7)的乘积对重症急性胰腺炎(SAP)相关性急性肾损伤(AKI)的早期预测价值。方法选取2018年3月至2021年3月新乡医学院第一附属医院收治的93例SAP患者为研究对... 目的探究尿基质金属蛋白酶抑制因子-2(TIMP-2)与胰岛素样生长因子结合蛋白7(IGFBP7)的乘积对重症急性胰腺炎(SAP)相关性急性肾损伤(AKI)的早期预测价值。方法选取2018年3月至2021年3月新乡医学院第一附属医院收治的93例SAP患者为研究对象,根据患者是否发生AKI分为AKI组(26例)和非AKI组(67例)。采用酶联免疫吸附法(ELISA)检测患者尿液中TIMP-2和IGFBP7水平;采用多因素logistic回归分析影响SAP患者发生AKI的危险因素;通过受试者工作特征(ROC)曲线分析SAP患者急性胰腺炎严重程度床边指数(Bisap)评分、尿液中TIMP-2与IGFBP7的乘积对发生AKI的预测价值。结果与非AKI组相比,AKI组患者Bisap评分、D-二聚体、降钙素原(PCT)、超敏C反应蛋白(hs-CRP)、TIMP-2与IGFBP7的乘积均上升,血钙水平降低(P<0.05)。AKI患者尿液TIMP-2与IGFBP7的乘积随AKI分级增加而上升(P<0.05)。Pearson相关性分析结果显示,AKI患者尿液TIMP-2与IGFBP7的乘积与Bisap评分、D-二聚体、PCT、hs-CRP均呈正相关(P<0.05),与血钙呈负相关(P<0.05)。多因素logistic回归分析结果显示,Bisap评分、TIMP-2与IGFBP7的乘积是影响SAP相关性AKI发生的危险因素(P<0.05)。ROC曲线分析结果显示,尿液TIMP-2与IGFBP7的乘积预测SAP患者发生AKI的曲线下面积(AUC)为0.923,高于Bisap评分预测的AUC(P<0.05)。结论SAP相关性AKI患者尿TIMP-2与IGFBP7的乘积异常升高,其高水平是SAP患者发生AKI的危险因素,且对发生AKI具有一定的预测价值。 展开更多
关键词 基质金属蛋白酶抑制因子-2 胰岛素样生长因子结合蛋白7 重症急性胰腺炎 急性肾损伤
下载PDF
外周血TIMP-1、TIMP-2及TSAT水平与腹膜透析相关性腹膜炎患者临床转归的关系
9
作者 李雅琪 郭宝珠 +1 位作者 程锦绣 金玉杰 《临床误诊误治》 CAS 2024年第13期40-44,共5页
目的分析腹膜透析相关性腹膜炎患者外周血基质金属蛋白酶抑制因子-1(TIMP-1)、基质金属蛋白酶抑制因子-2(TIMP-2)和转铁蛋白饱和度(TSAT)水平与临床转归的关系。方法选取2021年8月至2023年2月收治的100例腹膜透析相关性腹膜炎患者,根据... 目的分析腹膜透析相关性腹膜炎患者外周血基质金属蛋白酶抑制因子-1(TIMP-1)、基质金属蛋白酶抑制因子-2(TIMP-2)和转铁蛋白饱和度(TSAT)水平与临床转归的关系。方法选取2021年8月至2023年2月收治的100例腹膜透析相关性腹膜炎患者,根据患者拔除腹膜透析管后1年内临床转归情况将其分为治愈组(n=68)和恶化组(n=32)。比较2组临床资料及外周血TIMP-1、TIMP-2及TSAT水平,采用多因素Logistic回归分析影响腹膜透析相关性腹膜炎患者病情恶化的独立危险因素,采用受试者工作特征(ROC)曲线分析TIMP-1、TIMP-2及TSAT对患者临床转归的预测价值。结果恶化组透析龄高于治愈组,有腹膜炎病史患者占比大于治愈组,TIMP-1、TIMP-2和TSAT水平低于治愈组(P<0.01)。TIMP-1、TIMP-2和TSAT水平过低均是腹膜透析相关性腹膜炎患者病情恶化的独立危险因素(P<0.05)。ROC曲线分析显示,TIMP-1、TIMP-2和TSAT预测腹膜透析相关性腹膜炎患者临床转归的曲线下面积(AUC)分别为0.759、0.702和0.739,上述指标联合检测的AUC为0.813,具有更好的预测价值(P<0.05)。结论病情恶化的腹膜透析相关性腹膜炎患者TIMP-1、TIMP-2和TSAT水平降低,且三者及其联合检测对患者临床转归均有较高的预测价值。 展开更多
关键词 腹膜透析 腹膜炎 基质金属蛋白酶抑制因子-1 基质金属蛋白酶抑制因子-2 转铁蛋白饱和度 临床转归 危险因素 受试者工作特征曲线
下载PDF
TIMP-2和IGFBP-7早期预测急性肾损伤作用机制的研究进展
10
作者 徐凤娇 张宇 杨玉兰 《中国医药导报》 CAS 2024年第19期56-61,共6页
严重感染、缺血缺氧等导致急性肾损伤,使肾脏血管受损、肾小管中炎症细胞和促炎性细胞因子释放增多、糖酵解过程触发并上调。其中炎症细胞增多和血管受损导致小分子核糖核苷酸表达减少,从而上调小管上皮细胞中基质金属蛋白酶。金属蛋白... 严重感染、缺血缺氧等导致急性肾损伤,使肾脏血管受损、肾小管中炎症细胞和促炎性细胞因子释放增多、糖酵解过程触发并上调。其中炎症细胞增多和血管受损导致小分子核糖核苷酸表达减少,从而上调小管上皮细胞中基质金属蛋白酶。金属蛋白酶组织抑制因子-2(TIMP-2)可广泛抑制基质金属蛋白酶活性(优先与基质金属蛋白酶2结合),为恢复两者的动态平衡,TIMP-2表达增多,同时促炎性细胞因子可直接使小管上皮细胞分泌TIMP-2。转化生长因子β1参与急性肾损伤时胰岛素样生长因子结合蛋白-7(IGFBP-7)增多的过程。IGFBP-7可延长胰岛素、胰岛素样生长因子1半衰期,促进其与受体结合,延长相关通路的激活,并催化酪氨酸蛋白激酶活性,使磷酸果糖激酶活性提高,最终引起急性肾损伤肾小管上皮细胞中糖酵解过程激活、通量增多。TIMP-2与IGFBP-7能加重细胞周期停滞,可作为急性肾损伤细胞周期停滞的标志物。 展开更多
关键词 急性肾损伤 标志物 基质金属蛋白酶 金属蛋白酶组织抑制因子2 胰岛素样生长因子结合蛋白7
下载PDF
重度烧伤患者入院时尿[TIMP-2]×[IGFBP7]水平与早期肾损伤的关系
11
作者 杨孟 郭佳 孟祥林 《西部医学》 2024年第2期228-231,共4页
目的 探讨重度烧伤患者入院时尿组织金属蛋白酶抑制剂-2[TIMP-2]×胰岛素样生长因子结合蛋白7[IGFBP7]水平与早期肾损伤的关系。方法 选取2018年11月—2022年6月本院收治的77例重度烧伤患者设为重度组、77例轻中度烧伤患者设为轻中... 目的 探讨重度烧伤患者入院时尿组织金属蛋白酶抑制剂-2[TIMP-2]×胰岛素样生长因子结合蛋白7[IGFBP7]水平与早期肾损伤的关系。方法 选取2018年11月—2022年6月本院收治的77例重度烧伤患者设为重度组、77例轻中度烧伤患者设为轻中度组,另选取同期77例体检正常者为正常组。比较3组尿[TIMP-2]×[IGFBP7]水平及血清胱抑素C(CysC)水平。根据重度烧伤患者在住院期间是否发生肾早期损伤分为非肾损伤组(45例)和肾损伤组(32例),比较非肾损伤组、肾损伤组重度烧伤患者尿[TIMP-2]×[IGFBP7]水平及血清CysC水平。分析入院时尿[TIMP-2]×[IGFBP7]、血清CysC对重度烧伤患者并发肾损伤的预测价值。结果 重度组烧伤患者尿[TIMP-2]×[IGFBP7]水平及血清CysC水平高于正常组、轻中度组(P<0.05),轻中度组烧伤患者尿[TIMP-2]×[IGFBP7]水平及血清CysC水平高于正常组(P<0.05)。肾损伤组重度烧伤患者尿[TIMP-2]×[IGFBP7]、血清CysC水平高于非肾损伤组(P<0.05)。入院时尿[TIMP-2]×[IGFBP7]、血清CysC预测重度烧伤患者并发肾损伤的AUC分别为0.873、0.699,截断值分别为1.06 [(ng/mL)^(2)/1000]、5.52 mmol/L,灵敏度分别为84.4%、59.4%,特异度分别为89.9%,73.3%。结论 发生早期肾损伤的重度烧伤患者入院时尿[TIMP-2]×[IGFBP7]水平及血清CysC水平较高,[TIMP-2]×[IGFBP7]水平或可成为预测重度烧伤患者并发肾损伤的潜在指标,为临床评估重度烧伤并发肾损伤提供参考。 展开更多
关键词 重度烧伤 组织金属蛋白酶抑制剂-2 早期肾损伤 胰岛素样生长因子结合蛋白7
下载PDF
TISSUE FACTOR PATHWAY INHIBITOR-2 AS A PROGNOSTIC FACTOR IN PANCREATIC CARCINOMA
12
作者 俞建雄 袁静 王春友 《Medical Bulletin of Shanghai Jiaotong University》 CAS 2013年第1期12-18,共7页
Objective To establish the correlation between tissue factor pathway inhibitor 2 (TFPI-2) and the progression of pancreatic carcinoma(PC) after detecting the expression level of TFPI-2 in PC,and to evaluate the value ... Objective To establish the correlation between tissue factor pathway inhibitor 2 (TFPI-2) and the progression of pancreatic carcinoma(PC) after detecting the expression level of TFPI-2 in PC,and to evaluate the value of TFPI-2 as prognostic index in PC.Methods Expression levels of TFPI-2 in 10 normal and 25 cancerous/juxta-cancerous pancreas were testified with Western blot and RTPCR analyses respectively.Expression density of TFPI-2 in each group was analyzed with HPIAS image analyzer and compared with ANOVA.The correlation between the expression level of TFPI-2 and malignancy was tested with Spearman rank correlation.Disease-specific survival curves were calculated according to Kaplan Meier algorithm,and log rank test was used to compare survival curves.Then,Cox regression analysis was applied to determine the single contribution of each covariate on survival rate.Results The expression level of TFPI-2 decreased along with progression of PC with significant difference among groups (P <0.05),and there was a significantly negative correlation between TFPI-2 protein and progression (r= -ft 816,P <0.001).Among the 13 studied variables,such as the expression level of TFPI-2 protein, tumor stage,portal vein resection,lymph node metastasis,only lymph node metastasis was a predictor of outcome.However,when we analyzed the survival without considering lymph node metastasis,a stepwise Cox analysis showed that expression level of TFPI-2 protein and combined organ resection were significantly associated to survival.Conclusion The data showed that there was strongly correlation between the expression level of TFPI-2 and the progression and survival of PC,which suggested that TFPI-2 could be a newly prognostic factor and a novel approach for gene therapy for PC. 展开更多
关键词 tissue factor pathway inhibitor-2 PANCREATIC CARCINOMA PROGNOSIS
原文传递
高糖刺激下大鼠肾小球系膜细胞MMP-2,TIMP-2,MT1MMP 和CTGF的表达及意义 被引量:7
13
作者 姚芳 李志红 +3 位作者 闫喆 刘青娟 段惠军 郄涛 《解放军医学杂志》 CAS CSCD 北大核心 2013年第10期811-817,共7页
目的观察高糖刺激的大鼠肾小球系膜细胞基质金属蛋白酶-2(MMP-2)及其组织抑制物-2(TIMP-2)、膜型基质金属蛋白酶-1(MT1-MMP)和结缔组织生长因子(CTGF)的动态变化以探讨糖尿病肾病(DN)的发病机制。方法体外培养的大鼠HBZY-1肾小球系膜细... 目的观察高糖刺激的大鼠肾小球系膜细胞基质金属蛋白酶-2(MMP-2)及其组织抑制物-2(TIMP-2)、膜型基质金属蛋白酶-1(MT1-MMP)和结缔组织生长因子(CTGF)的动态变化以探讨糖尿病肾病(DN)的发病机制。方法体外培养的大鼠HBZY-1肾小球系膜细胞分为低糖(5.5mmol/L葡萄糖)组、高糖(30mmol/L葡萄糖)组和渗透压对照(5.5mmol/L葡萄糖+24.5mmol/L甘露醇)组,24、48、72、96h后采用RT-PCR及Western blotting法分别检测MMP-2、TIMP-2、MT1-MMP及CTGF的mRNA及蛋白表达情况,酶联免疫吸附法(ELISA)检测培养上清中Ⅳ型胶原的含量。结果 Western blotting结果显示,与低糖组相比,高糖组MMP-2的表达在24h时略有升高,较低糖组增加10%±4%(P<0.05),至48h时则较低糖组减少42%±2%,其后随时间延长表达持续降低,至96h时较低糖组减少78%±2%;MT1-MMP表达在24h开始下降并随时间呈下降趋势,与低糖组相比较,在刺激的24h,高糖组MT1-MMP表达下降了29%±3%,随后持续下降,至96h则下降了78%±9%(P<0.01)。高糖组各时间点TIMP-2和CTGF表达均较低糖组增高,其中CTGF的表达在高糖刺激的24h即显著增高,为低糖组的201%±24%,随后持续增高,至培养96h为低糖组的484%±51%(P<0.01);TIMP-2的表达在24h时较低糖组增加55%±3%,且随时间延长呈增高趋势(P<0.01)。MMP-2、TIMP-2、MT1-MMP和CTGF的mRNA表达与相应蛋白的表达趋势基本一致。与低糖组相比,高糖组细胞上清中的Ⅳ型胶原于24h即有增加,且持续增高至96h(P<0.05)。低糖组和渗透压对照组组内、组间的各指标差异均无统计学意义。结论尽管高糖刺激早期可小幅诱导MMP-2的表达增强,但长期高糖刺激则可抑制MMP-2和MT1-MMP的表达及活化,同时促进系膜细胞TIMP-2和CTGF的表达。DN中肾小球细胞外基质的积聚可能是由于上述细胞因子和蛋白酶引起细胞外基质代谢失衡所致。 展开更多
关键词 糖尿病肾病 肾小球系膜细胞 基质金属蛋白酶-2 基质金属蛋白酶组织抑制物-2 结缔组织生长因子 膜型基质金属蛋白酶-1
下载PDF
TFPI-2基因表达变化与声门上喉癌侵袭转移及预后的相关性研究 被引量:4
14
作者 孙亚男 刘鸣 +1 位作者 金德均 肖玉丽 《肿瘤》 CAS CSCD 北大核心 2008年第1期40-43,共4页
目的:探讨TFPI-2基因的表达与声门上喉癌侵袭转移及预后的关系。方法:运用反转录-聚合酶链反应(RT—PCR)及免疫组织化学方法检测TFPI-2在声门上喉癌组织中的表达,分析其与声门上喉癌临床病理特征的关系。结果:TFPI-2在声门上喉癌... 目的:探讨TFPI-2基因的表达与声门上喉癌侵袭转移及预后的关系。方法:运用反转录-聚合酶链反应(RT—PCR)及免疫组织化学方法检测TFPI-2在声门上喉癌组织中的表达,分析其与声门上喉癌临床病理特征的关系。结果:TFPI-2在声门上喉癌组织中mRNA和蛋白表达的阳性率明显增加(P〈0.05),TFPI-2 mRNA和蛋白表达随声门上喉癌的浸润深度的增加而降低(P〈0.05),在淋巴结转移组低于非淋巴结转移组(P〈0.05),在临床Ⅲ-Ⅳ期的表达低于临床Ⅰ-Ⅱ期(P〈0.05)。TFPI-2蛋白染色强度随声门上喉癌的侵袭程度增加及淋巴结转移而降低(P〈0.05)。TFPI-2蛋白表达阴性组声门上喉癌患者较阳性组者预后差(P〈0.05)。结论:TFPI-2表达下调可能与声门上喉癌的侵袭转移密切相关,可作为评估声门上喉癌淋巴结转移及预后的指标。 展开更多
关键词 喉肿瘤 组织途径抑制因子2 基因表达 肿瘤转移 预后
下载PDF
转染CTGF基因对乳腺癌细胞MMP-2及TIMP-2表达的影响 被引量:7
15
作者 许斌 陈寅 +4 位作者 戴桂红 蒋小芹 王薇 赵国军 于鸿 《江苏大学学报(医学版)》 CAS 2012年第2期97-100,共4页
目的:通过研究结缔组织生长因子(CTGF)基因对人乳腺癌MCF-7细胞株基质金属蛋白酶-2(MMP-2)、基质金属蛋白酶组织抑制因子-2(TIMP-2)表达的影响,深入探讨CTGF在乳腺癌侵袭和转移中的作用机制。方法:采用脂质体介导法,将CTGF基因瞬时转染... 目的:通过研究结缔组织生长因子(CTGF)基因对人乳腺癌MCF-7细胞株基质金属蛋白酶-2(MMP-2)、基质金属蛋白酶组织抑制因子-2(TIMP-2)表达的影响,深入探讨CTGF在乳腺癌侵袭和转移中的作用机制。方法:采用脂质体介导法,将CTGF基因瞬时转染体外培养的人MCF-7细胞,并用免疫荧光、RT-PCR和蛋白质印迹法检测其转染成功与否;再采用蛋白质印迹法检测转基因MCF-7 MMP-2及TIMP-2表达改变。结果:与对照组相比,转染CTGF基因的MCF-7,其CTGF mRNA和蛋白表达均显著增高,MMP-2蛋白表达水平显著增高,而TIMP-2蛋白表达水平显著降低。结论:CTGF可能通过增加乳腺癌细胞MMP-2表达及抑制TIMP-2的生成而起到促进乳腺癌侵袭和转移的作用。 展开更多
关键词 结缔组织生长因子 基质金属蛋白酶-2 基质金属蛋白酶组织抑制因子-2
下载PDF
组织因子途径抑制物2对卵巢癌细胞迁徙和浸润能力的影响 被引量:9
16
作者 仲任 黄瑞滨 宋善俊 《癌症》 SCIE CAS CSCD 北大核心 2003年第10期1038-1041,共4页
背景与目的:组织因子途径抑制物2(tissuefactorpathwayinhibitor-2,TFPI-2)是一种新近发现的丝氨酸蛋白酶抑制物,可抑制包括纤溶酶、胰蛋白酶、基质金属蛋白酶在内的多种蛋白酶,而对尿激酶、组织型纤溶酶原激活剂以及凝血酶没有抑制作... 背景与目的:组织因子途径抑制物2(tissuefactorpathwayinhibitor-2,TFPI-2)是一种新近发现的丝氨酸蛋白酶抑制物,可抑制包括纤溶酶、胰蛋白酶、基质金属蛋白酶在内的多种蛋白酶,而对尿激酶、组织型纤溶酶原激活剂以及凝血酶没有抑制作用。研究发现在多种肿瘤发生、发展过程中,TFPI-2常表达减少。本研究旨在探讨TFPI-2表达与卵巢癌细胞迁徙、浸润之间的关系。方法:脂质体介导人类TFPI-2真核表达载体pBos-Cite-neo/TFPI-2转染卵巢癌细胞株A2780,用G418筛选阳性细胞,经逆转录聚合酶链反应(reversetranscription-polymerasechainreaction,RT-PCR),Westernblot技术检测转染前后卵巢癌细胞中TFPI-2mRNA以及相应蛋白质表达水平;利用Boyden小室检测转染前后卵巢癌细胞穿膜的细胞数,此细胞数作为评价卵巢癌细胞迁徙、浸润能力的指标。结果:转染成功的卵巢癌细胞证实有TFPI-2mRNA和相应蛋白质的表达;与未转染的细胞相比,转染TFPI-2的细胞体外浸润能力显著下降(穿膜细胞数为59.3±6.5vs109.7±5.5,P<0.01);而迁徙能力无明显变化(穿膜细胞数为114.7±8.6vs127.3±7.1,P>0.05)。结论:TFPI-2表达可显著抑制卵巢癌细胞的浸润,为进一步开展肿瘤基因治疗提供实验依据。 展开更多
关键词 组织因子途径抑制物2 卵巢癌 癌细胞迁徙 癌细胞浸润
下载PDF
组织因子途径抑制物2在胰腺癌中表达的实验研究 被引量:7
17
作者 俞建雄 王春友 +2 位作者 陈立波 周峰 许逸卿 《中国现代医学杂志》 CAS CSCD 2004年第4期72-74,共3页
目的 组织因子途径抑制物 2 (TFPI- 2 )是一丝氨酸蛋白酶抑制物 ,在维持细胞外基质完整性和调控肿瘤细胞浸润转移方面起着重要作用。分析TFPI- 2和在人类胰腺癌中表达情况 ,探讨TFPI- 2与胰腺癌恶性程度之间的相互关系 ,为临床判断胰... 目的 组织因子途径抑制物 2 (TFPI- 2 )是一丝氨酸蛋白酶抑制物 ,在维持细胞外基质完整性和调控肿瘤细胞浸润转移方面起着重要作用。分析TFPI- 2和在人类胰腺癌中表达情况 ,探讨TFPI- 2与胰腺癌恶性程度之间的相互关系 ,为临床判断胰腺癌预后及后期的基因治疗奠定基础。方法 采用WesternBlot及RT -PCR方法 ,检测TFPI- 2在 2 0例临床胰腺癌标本及 8例正常胰腺组织中的表达情况 ,HPIAS图像分析仪分析各组标本相对密度 ,t检验各组相对密度差异 ,秩和检验TFPI- 2与胰腺癌恶性程度的相关性。结果 随着胰腺癌恶性程度的加深 ,TFPI- 2表达逐渐下降 ,两者之间存在着显著的负相关性。结论 TFPI- 2与胰腺癌恶性程度之间存在着负相关性 ,可能成为胰腺癌预后的判断指标之一 ,并为基因治疗胰腺癌提供新的方向。 展开更多
关键词 组织因子途径抑制物2(TFPI—2) 胰腺癌 预后
下载PDF
VEGF、MMP-2与TIMP-2在大肠癌中的表达 被引量:7
18
作者 李春光 刘铭球 +1 位作者 蒋辉 蓝海 《肿瘤防治研究》 CAS CSCD 2004年第1期21-23,共3页
目的 研究VEGF、MMP 2与TIMP 2在大肠癌组织中的表达、相互关系及与肿瘤生物学行为的相关性。方法 对 5 4例大肠癌患者的手术切除之癌组织和癌周正常组织 ,应用免疫组织化学方法检测其VEGF、基质金属蛋白酶MMP 2和组织金属蛋白酶... 目的 研究VEGF、MMP 2与TIMP 2在大肠癌组织中的表达、相互关系及与肿瘤生物学行为的相关性。方法 对 5 4例大肠癌患者的手术切除之癌组织和癌周正常组织 ,应用免疫组织化学方法检测其VEGF、基质金属蛋白酶MMP 2和组织金属蛋白酶抑制剂TIMP 2的表达情况 ,探讨两者之间的相互关系及其与肿瘤生物学行为的相关性。结果 VEGF、MMP 2与TIMP 2这三种蛋白在肿瘤组织中表达水平明显高于在正常组织中的表达。这三种蛋白的表达呈正相关 ,且表达水平与组织类型、组织分化程度、淋巴结转移、临床分期和五年生存率有统计学相关性 (P <0 .0 5 )。结论 大肠癌中VEGF、MMP 2与TIMP 2的表达 ,可能是癌肿发生、生长和浸润转移的重要因素 ,可作为判断肿瘤恶性程度的重要指标。 展开更多
关键词 VEGF MMP-2 TIMP-2 大肠癌 基质金属蛋白酶 组织金属蛋白酶抑制剂 血管内皮生长因子
下载PDF
参脉注射液对不稳定型心绞痛的治疗作用及其对组织因子途径抑制物2的影响 被引量:8
19
作者 吴连拼 陈刚 +2 位作者 高学忠 刘刚 艾力.买合木提 《中国动脉硬化杂志》 CAS CSCD 北大核心 2012年第10期908-910,922,共4页
目的研究参麦注射液对不稳定型心绞痛治疗疗效并了解其机制。方法入选178例不稳定型心绞痛患者,分为治疗组和对照组,治疗组为常规西药治疗基础上加用参麦注射液,对照组常规西药治疗加极化液注射注射。观察心绞痛症状及心电图缓解情况,... 目的研究参麦注射液对不稳定型心绞痛治疗疗效并了解其机制。方法入选178例不稳定型心绞痛患者,分为治疗组和对照组,治疗组为常规西药治疗基础上加用参麦注射液,对照组常规西药治疗加极化液注射注射。观察心绞痛症状及心电图缓解情况,并检测治疗前后患者血浆组织因子途径抑制物2的浓度。结果治疗组及对照组基线情况基本相同。治疗组及对照组症状缓解率分别为84.3%和69.7%,心电图好转率分别为74.5%和61.8%,两者比较均差异具有显著(P<0.05)。治疗前后患者血浆组织因子途径抑制物2均有下降,但前后差值治疗组下降明显,两者比较差异具有显著性(P<0.01)。结论在常规西药治疗基础上加用参麦注射液可有效缓解不稳定型心绞痛的发作,参脉注射液对不稳定型心绞痛的治疗作用可能与不稳定型心绞痛患者血浆组织因子途径抑制物2水平变化相关。 展开更多
关键词 参麦注射液 不稳定型心绞痛 组织因子途径抑制物2
下载PDF
5-Aza-CdR对非小细胞肺癌细胞株A549细胞TFPI-2基因甲基化水平及表达的影响 被引量:5
20
作者 梁江水 董永强 +3 位作者 殷桂林 朱水波 张晓明 纪涛 《实用医学杂志》 CAS 北大核心 2013年第21期3475-3478,共4页
目的:探讨甲基化酶抑制剂5-氮杂-2′-脱氧胞苷(5-aza-2-deoxycytidine,5-Aza-CdR)对非小细胞肺癌(NSCLC)细胞株A549中抑癌基因组织因子途径抑制物2(TFPI-2)基因甲基化水平及基因表达的影响。方法:用不同浓度的5-Aza-CdR[(1、5、10)×... 目的:探讨甲基化酶抑制剂5-氮杂-2′-脱氧胞苷(5-aza-2-deoxycytidine,5-Aza-CdR)对非小细胞肺癌(NSCLC)细胞株A549中抑癌基因组织因子途径抑制物2(TFPI-2)基因甲基化水平及基因表达的影响。方法:用不同浓度的5-Aza-CdR[(1、5、10)×10-6mol/L]处理肺癌细胞株A549细胞,不加药物(0 mol/L)作为对照组。药物处理72 h后,甲基化特异性PCR(MSP)检测A549细胞TFPI-2基因的甲基化状态;Real-time PCR技术检测A549细胞TFPI-2基因mRNA的表达;Western blot检测A549细胞TFPI-2蛋白的表达。结果:MSP检测到对照组A549细胞TFPI-2基因呈高甲基化状态,5-Aza-CdR处理异常甲基化得到逆转。Real-time PCR检测显示(0、1、5、10)×10-6mol/L的5-Aza-CdR处理A549细胞72 h后,相对mRNA表达水平分别为1±0、1.49±0.14、1.86±0.09、5.80±0.15(P<0.05),TFPI-2基因mRNA表达呈明显的上升趋势,且随着药物浓度增加而增加。Western blot分析结果显示,对照组与(1、5、10)×10-6mol/L的5-Aza-CdR组的TFPI-2蛋白表达相对水平分别为0.12±0.01、0.23±0.02、0.31±0.02、0.62±0.03(P<0.05)。结论:5-Aza-CdR能成功逆转肺癌A549细胞中TFPI-2基因的高甲基化状态,并恢复TFPI-2基因mRNA及蛋白的表达。 展开更多
关键词 肺肿瘤 5-氮杂-2’-脱氧胞苷 组织因子途径抑制物2 甲基化
下载PDF
上一页 1 2 14 下一页 到第
使用帮助 返回顶部